3 recruiting, 1 completed, 1 unknown. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Recruiting 3, Completed 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Locally Advanced Cervical Cancer: new trials by email Literature Review of Locally Advanced Cervical Cancer trials Research Report on Locally Advanced Cervical Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC Camrelizumab, Cisplatin, Nab paclitaxel - Cervical Cancer, Locally Advanced Cervical Cancer | Phase 2 / Phase 3 | Recruiting | Tongji Hospital | 440 | 2024-04-22 | 2024-10-30 |
| Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical) Volrustomig, Placebo - Locally Advanced Cervical Cancer | Phase 3 | Recruiting | AstraZeneca | 800 | 2023-09-22 | 2026-09-30 |
| Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer Gemcitabine, Cisplatin - Locally Advanced Cervical Cancer, Gemcitabine | Phase 3 | Recruiting | National Institute of Cancerología | 140 | 2019-11-06 | 2025-05-28 |
| Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) Durvalumab, Cisplatin, Carboplatin - Locally Advanced Cervical Cancer | Phase 3 | Completed | AstraZeneca | 770 | 2019-02-15 | 2024-07-26 |
| Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer Cisplatin - Locally Advanced Cervical Cancer | Phase 3 | Unknown | National University Hospital, Singapore | 2008-05-15 |
Uterine Cervical Neoplasms (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Neoplasms (1) · Neoplasms by Site (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Uterine Cervical Diseases (1) · Uterine Diseases (1) · Uterine Neoplasms (1)
Cisplatin (4) · Brachytherapy (2) · Carboplatin (1) · Gemcitabine (1) · Sodium Chloride (1) · Taxes (1) · camrelizumab (1) · durvalumab (1)
AstraZeneca (2) · National Institute of Cancerología (1) · National University Hospital, Singapore (1) · Tongji Hospital (1)
China (3) · Mexico (3) · Brazil (2) · India (2) · Japan (2) · Peru (2) · Poland (2) · South Korea (2) · Taiwan (2) · United States (2) · Canada (1) · Chile (1) · Denmark (1) · Germany (1) · Hungary (1)
Bradley Monk, M.D (1) · Ding Ma (1) · Eder A Arango, MD (1) · Johann Tang (1) · Lucely C Cetina, MSc, PhD (1) · Urban Scheuring, M.D., Ph.D. (1)
2018 (1), 2023 (1)